一抗-第70页-西安迈博睿（Mabioway）生物科技有限公司

当前分类：一抗

| 下级分类：

Item	Cat. No.	Application	Isotype
Anti-IL-12 mAbs [12E3](MABL-2021)	MABL-2021	ELISA	Engineer antibody
Anti-IL-12 mAbs [7G11](MABL-2022)	MABL-2022	ELISA	Engineer antibody
Anti-IL-12/IL-23p40 mAbs [CNTO 1275 (Ustekinumab)](MABL-2023)	MABL-2023	in vivo, therapeutic, Block	Engineer antibody
Anti-IL-12RB2 mAbs [IL12Rb2#1](MABL-2024)	MABL-2024	FACS, inhibition, SPR, ELISA	Engineer antibody
Anti-IL-12RB2 mAbs [IL12Rb2#2](MABL-2025)	MABL-2025	FACS, inhibition, SPR, ELISA	Engineer antibody
Anti-IL-13 mAbs [13-62](MABL-2026)	MABL-2026	ELISA	Engineer antibody
Anti-IL-13 mAbs [6A1](MABL-2027)	MABL-2027	inhibition, neutralization, SPR, ELISA	Engineer antibody
Anti-IL-13 mAbs [CNTO607](MABL-2028)	MABL-2028	neutralize, ELISA	Engineer antibody
Anti-IL-13 mAbs [DOM10-53-616](MABL-2029)	MABL-2029	neutralize, ELISA	Engineer antibody
Anti-IL-13 mAbs [M1295](MABL-2030)	MABL-2030	neutralize, therapeutic, ELISA	Engineer antibody
Anti-IL-15 mAbs [M4-7](MABL-2031)	MABL-2031	neutralizing, WB, ELISA	Engineer antibody
Anti-IL-16 mAbs [14.1](MABL-2032)	MABL-2032	WB, ELISA, FC, IHC	Engineer antibody
Anti-IL-17 mAbs [Antibody 7](MABL-2033)	MABL-2033	crystallization, functional assays, in vivo, SPR, ELISA	Engineer antibody
Anti-IL-17 mAbs [IL-17M70](MABL-2034)	MABL-2034	SPR	Engineer antibody
Anti-IL-17 mAbs [MCAF5352A (Afasevikumab)](MABL-2035)	MABL-2035	neutralize, SPR, Block, ELISA	Engineer antibody
Anti-IL-17A mAbs [1G8](MABL-2036)	MABL-2036	WB, ELISA, FC	Engineer antibody
Anti-IL-17A mAbs [3D11](MABL-2037)	MABL-2037	WB, ELISA	Engineer antibody
Anti-IL-17a mAbs [Cnto7357](MABL-2038)	MABL-2038	ELISA	Engineer antibody
Anti-IL-17A mAbs [MM17F3](MABL-2039)	MABL-2039	Blocking, therapeutic, ELISA	Engineer antibody
Anti-IL-17F mAbs [8F5.1A9](MABL-2040)	MABL-2040	FC	Engineer antibody

首页上一页 65 66 67 68 69 70 71 72 73 74 75 下一页末页